View:
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* ------ CytoTherapeutics, Inc. ---------------------------------- (Name of Issuer) Common ---------------------------------- (Title of Class of Securities) 232923102 ---------------------------------- (CUSIP Number) Check the following box if a fee is being paid with this statement / /. (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7.) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (Continued on following page(s)) Page 1 of 5 Pages --- CUSIP No. 232923102 13G Page 2 of 5 Pages --------- --- --- - ------------------------------------------------------------------------------- (1) Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above Persons The St. Paul Companies, Inc. 385 Washington Street St. Paul, Minnesota 55102 IRS #41-0518860 - ------------------------------------------------------------------------------- (2) Check the Appropriate Box if a Member (a) / / of a Group* (b) / / - ------------------------------------------------------------------------------- (3) SEC Use Only - ------------------------------------------------------------------------------- (4) Citizenship or Place of Organization Minnesota corporation - ------------------------------------------------------------------------------- Number of Shares (5) Sole Voting Power Beneficially None Owned by -------------------------------------------------- Each Reporting (6) Shared Voting Power Person With None -------------------------------------------------- (7) Sole Dispositive Power None -------------------------------------------------- (8) Shared Dispositive Power None (see remark in Item 6) - ------------------------------------------------------------------------------ (9) Aggregate Amount Beneficially Owned by Each Reporting Person None - ------------------------------------------------------------------------------- (10) Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares* - ------------------------------------------------------------------------------- (11) Percent of Class Represented by Amount in Row (9) None - ------------------------------------------------------------------------------- (12) Type of Reporting Person* HC - ------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! Page 3 of 5 Pages --- --- ITEM 1(A). NAME OF ISSUER CytoTherapeutics, Inc. - ------------------------------------------------------------------------------- ITEM 1(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES Four Richmond Square Providence, RI 02906 - ------------------------------------------------------------------------------- ITEM 2(A). NAME OF PERSON(S) FILING The St. Paul Companies, Inc. - ------------------------------------------------------------------------------- ITEM 2(B). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE 385 Washington Street St. Paul, MN 55102 - ------------------------------------------------------------------------------- ITEM 2(C). CITIZENSHIP Minnesota Corporation - ------------------------------------------------------------------------------- ITEM 2(D). TITLE OF CLASS OF SECURITIES Common - ------------------------------------------------------------------------------- ITEM 2(E). CUSIP NUMBER 232923102 - ------------------------------------------------------------------------------- ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13D-1(B), OR 13D-2(B), CHECK WHETHER THE PERSON FILING IS A (g) /X/ Parent Holding Company ITEM 4. OWNERSHIP Not Applicable Page 4 of 5 Pages --- --- ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following. /X/ ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON Not Applicable - ------------------------------------------------------------------------------- ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY St. Paul Fire and Marine Insurance Company is an Insurance Company under Reg.240.13d-1(b)(1)(ii)(C) - ------------------------------------------------------------------------------- ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP Not Applicable - ------------------------------------------------------------------------------- ITEM 9. NOTICE OF DISSOLUTION OF GROUP Not Applicable - ------------------------------------------------------------------------------- ITEM 10. CERTIFICATION By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 11, 1994 ---------------------------------------- (Date) ---------------------------------------- (Signature) ---------------------------------------- Bruce A. Backberg Title: Vice President & Corporate Secretary SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G EXHIBIT A-DISCLAIMER Information on the attached Schedule 13G is provided solely for the purpose of complying with Section 13(d) and 13(g) of the Securities Exchange Act of 1934 and Regulation promulgated under authority thereof and is not intended as an admission the St. Paul Companies, Inc. or any of its subsidiaries, is a beneficial owner of the securities described herein for and other purpose.